Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial

Introduction The optimal antithrombotic strategy for patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is uncertain. For patients with non-AF, many trials are now evaluating short 1-month dual antiplatelet therapy. In patients with AF undergoing PCI, in contr...

Full description

Bibliographic Details
Main Authors: Kenji Ando, Ken Kozuma, Kosuke Kashiwabara, Shungo Hikoso, Yasushi Sakata, Yoshiharu Higuchi, Yohei Sotomi, Junya Ako, Gaku Nakazawa, Yoshihiro Morino, Kengo Tanabe, Takashi Muramatsu
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e048354.full

Internet

https://bmjopen.bmj.com/content/11/12/e048354.full

Similar Items